Tech Company Financing Transactions
Xytis Funding Round
Sanderling Ventures and private investors participated in a $7.5 million funding round for Xytis. The round was announced on 9/30/2007.
Transaction Overview
Company Name
Announced On
9/30/2007
Transaction Type
Venture Equity
Amount
$7,500,000
Round
Undisclosed
Investors
Sanderling Ventures (Roger Flugel)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
101 Theory 100
Irvine, CA 92617
USA
Irvine, CA 92617
USA
Phone
Website
Email Address
Overview
Xytis Inc. is a biopharmaceutical company focusing on the discovery and development of innovative CNS drug candidates.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Vincent Simmon
Browse more venture capital transactions:
Prev: 9/30/2007: MedServe venture capital transaction
Next: 9/30/2007: Local Marketers venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on funding rounds that are announced publicly. VC investment data records on this site are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs